GLPG Stock Price | Galapagos NV ADR P/E, Revenue, EPS, & Forecasts

Galapagos NV ADR • GLPG

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Galapagos NV ADR

Ticker

GLPG

Trading on

NASDAQ

ISIN

US36315X1019

Industry

Biotechnology

Sector

Healthcare

CEO

Henry Gosebruch

Headquarters

Generaal De Wittelaan L11 A3, Mechelen, undefined, Belgium, 2800

Employees

704

Website

glpg.com

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Metrics

BasicAdvanced

Market cap

$2.09B

P/E ratio

EPS

-$7.88

Dividend Yield

0.00%

Beta

-0.05

Forward P/E ratio

344.83

EBIDTA

$-277M

Ex dividend date

Price & volume

Market cap

$2.09B

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

344.83

PEG ratio

Trailing P/E

Price to sales

7.28

Price to book

0.73

Earnings

EPS

-$7.88

EPS estimate (current quarter)

-$0.28

EPS estimate (next quarter)

$0.23

EBITDA

$-277M

Revenues (TTM)

$287M

Revenues per share (TTM)

$0.22

Technicals

Beta

-0.05

52-week High

$37.78

52-week Low

$22.36

50-day moving average

$32.24

200-day moving average

$29.76

Short ratio

7.05

Short %

2.48%

Management effectiveness

ROE (TTM)

-16.72%

ROA (TTM)

-5.19%

Profit margin

-151.94%

Gross profit margin

$-207M

Operating margin

-58.56%

Growth

Quarterly earnings growth (YoY)

74.80%

Quarterly revenue growth (YoY)

18.90%

Share stats

Outstanding Shares

65.9M

Float

44.5M

Insiders %

25.35%

Institutions %

23.02%

Analyst Insights & forecasts

1% Buy

66% Hold

33% Sell

Based on information from 6 analysts.

Average price target

$27.81

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.30

$0.28

7.96%

Q4 • 24Beat

-$2.45

-$0.18

-1,261.11%

Q1 • 25Missed

-$1.58

-$0.23

-592.07%

Q2 • 25Missed

-$3.54

-$0.35

-903.12%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$65.3M

$-106M

-161.97%

Q2 • 25

$71.2M

$-202M

-284.02%

Q3 • 25

9.00%

91.13%

75.35%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$3.82B

$1.17B

30.76%

Q2 • 25

$4.13B

$1.25B

30.32%

Q3 • 25

8.07%

6.55%

-1.41%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-109M

$74.7M

$-0.6M

$-113M

Q2 • 25

$-62.6M

$56.7M

$-1.3M

$-65.5M

Q3 • 25

-42.45%

-24.05%

109.50%

-42.04%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Galapagos NV ADR share?

Galapagos NV ADR shares are currently traded for undefined per share.

How many shares does Galapagos NV ADR have?

Galapagos NV ADR currently has 65.9M shares.

Does Galapagos NV ADR pay dividends?

No, Galapagos NV ADR doesn't pay dividends.

What is Galapagos NV ADR 52 week high?

Galapagos NV ADR 52 week high is $37.78.

What is Galapagos NV ADR 52 week low?

Galapagos NV ADR 52 week low is $22.36.

What is the 200-day moving average of Galapagos NV ADR?

Galapagos NV ADR 200-day moving average is $29.76.

Who is Galapagos NV ADR CEO?

The CEO of Galapagos NV ADR is Henry Gosebruch.

How many employees Galapagos NV ADR has?

Galapagos NV ADR has 704 employees.

What is the market cap of Galapagos NV ADR?

The market cap of Galapagos NV ADR is $2.09B.

What is the P/E of Galapagos NV ADR?

The current P/E of Galapagos NV ADR is null.

What is the EPS of Galapagos NV ADR?

The EPS of Galapagos NV ADR is -$7.88.

What is the PEG Ratio of Galapagos NV ADR?

The PEG Ratio of Galapagos NV ADR is 0.

What do analysts say about Galapagos NV ADR?

According to the analysts Galapagos NV ADR is considered a hold.